Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium

Authors: Spigel, David R., Hainsworth, John D., Shipley, Dianna L., Mekhail, Tarek M., Zubkus, John D., Waterhouse, David M., Daniel, Davey B., Burris, Howard A., III, Greco, F. Anthony

Source: In Lung Cancer March 2018 117:38-43

A Randomized, Double‐Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX‐427) in Patients with Previously Untreated Stage IV Non‐Squamous‐Non‐Small‐Cell Lung Cancer: The SPRUCE Trial

Authors: Spigel, David R., Shipley, Dianna L., Waterhouse, David M., Jones, Suzanne F., Ward, Patrick J., Shih, Kent C., Hemphill, Brian, McCleod, Michael, Whorf, Robert C., Page, Ray D., Stilwill, Joseph, Mekhail, Tarek, Jacobs, Cindy, Burris, Howard A., Hainsworth, John D.

Source: Oncologist. 24(12):e1409-e1416

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100093957898.0x000001&indx=1&recIds=ETOCvdc_100093957898.0x000001

Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI)

Authors: Spigel, David R., Rubin, Mark S., Gian, Victor G., Shipley, Dianna L., Burris, Howard A., III, Kosloff, Rebecca A., Shih, Kent C., Quinn, Raven, Greco, F. Anthony, Hainsworth, John D.

Source: In Lung Cancer November 2017 113:79-84

High-Dose Bevacizumab in the Treatment of Patients With Advanced Clear Cell Renal Carcinoma: A Phase II Trial of the Sarah Cannon Oncology Research Consortium

Authors: Hainsworth, John D., Shipley, Dianna L., Reeves, James, Jr, Arrowsmith, Edward R., Barnes, Edward K., Waterhouse, David M.

Source: In Clinical Genitourinary Cancer September 2013 11(3):283-289

Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer

Authors: Spigel, David R., Anthony Greco, F., Waterhouse, David M., Shipley, Dianna L., Zubkus, John D., Bury, Martin J., Webb, Charles D., Hart, Lowell L., Gian, Victor G., Infante, Jeffrey R., Burris, Howard A., III, Hainsworth, John D.

Source: In Lung Cancer October 2012 78(1):70-75

Phase II Study of Bevacizumab and Chemoradiation in the Preoperative or Adjuvant Treatment of Patients With Stage II/III Rectal Cancer

Authors: Spigel, David R., Bendell, Johanna C., McCleod, Michael, Shipley, Dianna L., Arrowsmith, Edward, Barnes, E. Kirk, Infante, Jeffrey R., Burris, Howard A., III, Greco, F. Anthony, Hainsworth, John D.

Source: In Clinical Colorectal Cancer March 2012 11(1):45-52

A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer

Authors: Spigel, David R., Hainsworth, John D., Shipley, Dianna L., Ervin, Thomas J., Kohler, Peter C., Lubiner, Eric T., Peyton, James D., Waterhouse, David M., Burris, Howard A., III, Greco, F. Anthony

Source: In Journal of Thoracic Oncology January 2012 7(1):196-202

A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer

Authors: Spigel, David R., Greco, F. Anthony, Burris, Howard A., III, Shipley, Dianna L., Clark, Bobby L., Whorf, Robert C., Arrowsmith, Edward R., Hainsworth, John D.

Source: In Clinical Lung Cancer May 2011 12(3):187-191

Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium

Authors: Hainsworth, John D., Waterhouse, David M., Penley, William C., Shipley, Dianna L., Thompson, Dana S., Webb, Charles D., Anthony Greco, F.

Source: Cancer investigation. 31(5):323-329

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103149380.0x000001&indx=1&recIds=ETOCvdc_100103149380.0x000001

A Randomized, Double‐Blinded, Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial

Authors: Ko, Andrew H., Murphy, Patrick B., Peyton, James D., Shipley, Dianna L., Al‐Hazzouri, Ahmed, Rodriguez, Francisco A., Womack, Mark S., Xiong, Henry Q., Waterhouse, David M., Tempero, Margaret A., Guo, Shuangli, Lane, Cassie M., Earwood, Chris, DeBusk, Laura M., Bendell, Johanna C.

Source: Oncologist. 22(12):1427-e129

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100086734886.0x000001&indx=1&recIds=ETOCvdc_100086734886.0x000001

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

A Phase II Trial of Bendamustine, Bortezomib, and Rituximab in Patients with Previously Untreated Low Grade Lymphoma

Authors: Flinn, Ian W., Ervin, Thomas J. ^*, Boccia, Ralph V., Flora, Douglas B. ^*, Cuevas, J. Daniel ^*, Thompson, Dana S. ^*, Shipley, Dianna L. ^*, Berdeja, Jesus G.

Source: In Blood 3 December 2015 126(23):1492-1492

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.